CD4 and metastatic malignant neoplasm: It is important to acknowledge that a low CD4/CD8 ratio was considered an immune risk phenotype and was associated with the risk for chronic inflammation, frailty, age-related disease, and poor prognosis in different diseases such as systemic lupus erythematosus, metastatic cancer, diabetes and myocardial infarction [52–55].